01292nas a2200469   4500000000100000000000100001000000100002008004100003653003100044653005200075653001000127653003900137653002800176653004600204653001000250653002500260653001100285653004900296653001100345653003500356653002500391653000900416653001600425653001900441653001500460653002800475653003200503653001600535653001300551653002200564653001100586653002100597653001400618100001300632700001600645700001600661245008000677250001500757300001000772490000800782020003200790       2022                            d10aAdministration, Inhalation10aAdrenal Cortex Hormones/administration & dosage10aAdult10aAsthma/*complications/drug therapy10aCOVID-19/*complications10aCritical Care/statistics & numerical data10aDeath10aEngland/epidemiology10aFemale10aHospitalization/*statistics & numerical data10aHumans10aInfluenza, Human/complications10aLongitudinal Studies10aMale10aMiddle Aged10aPatient Acuity10a*Phenotype10aPneumonia/complications10aProportional Hazards Models10a*SARS-CoV-210aCovid-1910aallergic rhinitis10aAsthma10adisease severity10ainfluenza1 aC. Bloom1 aP. Cullinan1 aJ. Wedzicha00aAsthma Phenotypes and COVID-19 Risk: A Population-based Observational Study  a2021/10/21  a36-450 v205  a1073-449X (Print)
1073-449x